PI
Replying to @nihon_nohyaku
ZLD is increasingly mandated by regulation. Operating cost is the challenge.
@ppg_ind
Replying to @nihon_nohyaku
ZLD is increasingly mandated by regulation. Operating cost is the challenge.
Replying to @airliquide
ASD stability depends critically on the drug-polymer interaction. Good choice of carrier.
Replying to @meiji_seika
Cell-free protein synthesis achieved gram-per-liter titers for our target protein.
Replying to @golden_pharma
The regulatory landscape for this category is evolving under ICH Q14 guidelines.